TrialJournal of cardiovascular electrophysiology2026

Self-Administered Etripamil Nasal Spray Slows Ventricular Rate in Patients With Atrial Fibrillation: A Post Hoc Analysis of the NODE-303 Study.

Paul Dorian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.